As the novel coronavirus continues to spread globally and across Africa, efforts are being accelerated to identify effective preventive and therapeutic measures to mitigate its burden. Convalescent plasma and hyperimmune immunoglobulin are being considered as potential therapeutic options for the coronavirus disease 2019 (COVID-19). We highlight and contextualize the findings of a recent Cochrane rapid review that evaluated the effectiveness and safety of convalescent plasma or hyperimmune immunoglobulin transfusion in the treatment of people with COVID-19. From the eight studies it included, the review found limited and low-certainty evidence on the effectiveness and safety of convalescent plasma therapy in patients with COVID-19. The evidence was limited by the small number of participants and low-quality of included studies, as well as the inconsistency of outcome measures and reporting across studies. As African countries brace for the further spread of the virus, while exploring potential therapeutic options to mitigate its morbidity and mortality at peak, convalescent plasma transfusion may offer a therapeutic ray of hope for the continent. Considering the limited evidence of the effectiveness and safety in the treatment of COVID-19, it is imperative for this therapy to be investigated within African contexts to ascertain not only its effectiveness and safety, but also its practical implications within the capacity of national blood transfusion services and health systems in the region.
【저자키워드】 COVID-19, convalescent plasma, coronavirus, transfusion, hyperimmune immunoglobulin, 【초록키워드】 Treatment, coronavirus disease, therapy, virus, Novel coronavirus, Spread, Convalescent plasma therapy, Immunoglobulin, African, therapeutic, Effectiveness, plasma, morbidity and mortality, health system, Blood, Evidence, therapeutic option, outcome measure, measure, effort, participant, National, offer, mitigate, implication, country, effective, hyperimmune, highlight, identify, investigated, evaluated, eight, imperative, accelerated, patients with COVID-19, people with COVID-19, 【제목키워드】 Immunoglobulin, hyperimmune, people with COVID-19,